| R-HSA-109581 |
Apoptosis |
| R-HSA-109606 |
Intrinsic Pathway for Apoptosis |
| R-HSA-111447 |
Activation of BAD and translocation to mitochondria |
| R-HSA-114452 |
Activation of BH3-only proteins |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1445148 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1643685 |
Disease |
| R-HSA-165159 |
MTOR signalling |
| R-HSA-166208 |
mTORC1-mediated signalling |
| R-HSA-166520 |
Signaling by NTRKs |
| R-HSA-166520 |
Signaling by NTRKs |
| R-HSA-168256 |
Immune System |
| R-HSA-169893 |
Prolonged ERK activation events |
| R-HSA-169893 |
Prolonged ERK activation events |
| R-HSA-170968 |
Frs2-mediated activation |
| R-HSA-170968 |
Frs2-mediated activation |
| R-HSA-170984 |
ARMS-mediated activation |
| R-HSA-187037 |
Signaling by NTRK1 (TRKA) |
| R-HSA-187037 |
Signaling by NTRK1 (TRKA) |
| R-HSA-187687 |
Signalling to ERKs |
| R-HSA-187687 |
Signalling to ERKs |
| R-HSA-194315 |
Signaling by Rho GTPases |
| R-HSA-195258 |
RHO GTPase Effectors |
| R-HSA-199991 |
Membrane Trafficking |
| R-HSA-2028269 |
Signaling by Hippo |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-3700989 |
Transcriptional Regulation by TP53 |
| R-HSA-392517 |
Rap1 signalling |
| R-HSA-450385 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA |
| R-HSA-450513 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA |
| R-HSA-450531 |
Regulation of mRNA stability by proteins that bind AU-rich elements |
| R-HSA-5357801 |
Programmed Cell Death |
| R-HSA-5625740 |
RHO GTPases activate PKNs |
| R-HSA-5628897 |
TP53 Regulates Metabolic Genes |
| R-HSA-5653656 |
Vesicle-mediated transport |
| R-HSA-5663202 |
Diseases of signal transduction by growth factor receptors and second messengers |
| R-HSA-5673000 |
RAF activation |
| R-HSA-5673001 |
RAF/MAP kinase cascade |
| R-HSA-5674135 |
MAP2K and MAPK activation |
| R-HSA-5675221 |
Negative regulation of MAPK pathway |
| R-HSA-5683057 |
MAPK family signaling cascades |
| R-HSA-5684996 |
MAPK1/MAPK3 signaling |
| R-HSA-6802946 |
Signaling by moderate kinase activity BRAF mutants |
| R-HSA-6802948 |
Signaling by high-kinase activity BRAF mutants |
| R-HSA-6802949 |
Signaling by RAS mutants |
| R-HSA-6802952 |
Signaling by BRAF and RAF fusions |
| R-HSA-6802955 |
Paradoxical activation of RAF signaling by kinase inactive BRAF |
| R-HSA-6802957 |
Oncogenic MAPK signaling |
| R-HSA-69473 |
G2/M DNA damage checkpoint |
| R-HSA-69481 |
G2/M Checkpoints |
| R-HSA-69620 |
Cell Cycle Checkpoints |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-75035 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex |
| R-HSA-8953854 |
Metabolism of RNA |
| R-HSA-9006934 |
Signaling by Receptor Tyrosine Kinases |
| R-HSA-9006934 |
Signaling by Receptor Tyrosine Kinases |
| R-HSA-9607240 |
FLT3 Signaling |
| R-HSA-9614085 |
FOXO-mediated transcription |
| R-HSA-9614399 |
Regulation of localization of FOXO transcription factors |
| R-HSA-9649948 |
Signaling downstream of RAS mutants |
| R-HSA-9656223 |
Signaling by RAF1 mutants |
| R-HSA-9660537 |
Signaling by MRAS-complex mutants |
